Novo Nordisk

0:18:14

Wie Novo Nordisk zum wertvollsten Unternehmen Europas wurde

0:05:18

Novo Nordisk: 45 % Crash – Jetzt kaufen oder fällt die Aktie noch weiter?

0:03:26

TIME100 Most Influential Companies: Novo Nordisk

0:00:55

Novo Nordisk's Wegovy Drops Price to $499

0:26:43

Investeringspodcasten 266: Kursen på Novo Nordisk, Computere køber aktier og Tysklands økonomi

0:12:41

Novo Nordisk in der Krise - Diese Fakten musst du kennen | Novo Nordisk Aktie Analyse und Prognose

0:00:55

The Novo Nordisk Corporate Structure

0:04:01

BMO’s Evan David Seigerman cuts Novo Nordisk price target after Cagrisema data disappoints

0:00:52

Ozempic Maker Novo Nordisk Has Denmark’s Economy Hooked

0:03:01

Novo Nordisk CEO expects same growth for 2025

0:00:58

Weight-Loss Drugs Ozempic, Wegovy Propel Novo Nordisk Into Spotlight

0:16:26

Novo Nordisk CRASHED 50% - Ridiculously Cheap or a Falling Knife?

0:00:45

Novo Nordisk Ozempic

0:02:53

Novo Nordisk and Eli Lilly will dominate the obesity drug market long-term, says Mizuho's Jared Holz

0:01:14

Novo Nordisk CEO shares his outlook for Wegovy pricing in the U.S.

0:01:00

Novo Nordisk Transformed Diabetes Care with Insulin Pens

0:15:29

Action Novo Nordisk : - 47% en Bourse… Opportunité ou danger ? On analyse l’entreprise !

0:01:29

Join us in Novo Nordisk Manufacturing

0:08:54

How Novo Nordisk Became Europe's most Valuable Company

0:26:28

Novo Nordisk Aktien-Update 2025 - Jetzt schon zugreifen?

0:01:29

Novo Nordisk must lower the cost of Ozempic

0:01:31

Novo Nordisk plunges after obesity drug trial disappoints | REUTERS

0:04:35

Novo Nordisk Selloff Is an Overreaction, Barclays' Field Says